bioRxiv · 10.1101/223180
quanTIseq: quantifying immune contexture of human tumors
Abstract
The immune contexture has a prognostic value in several cancers and the study of its pharmacological modulation could identify drugs acting synergistically with immune checkpoint blockers. However, the quantification of the immune contexture is hampered by the lack of simple and efficient methods. We developed quanTIseq, a deconvolution method that quantifies the densities of ten immune cell types from bulk RNA sequencing data and tissue imaging data. We performed extensive validation using simulated data, flow cytometry data, and immunohistochemistry data from three cancer cohorts.\n\nAnalysis of 8,000 samples showed that the activation of the CXCR3/CXCL9 axis, rather than the mutational load is associated with cytotoxic T cell infiltration. We also show the prognostic value of deconvolution-based immunoscore and T cell/B cell score in several solid cancers. Finally, we used quanTIseq to show how kinase inhibitors modulate the immune contexture, and we suggest that it might have predictive value for immunotherapy.
Source connections
Explore related subjects
Keep this discovery
Finotello, F., Mayer, C., Plattner, C., Laschober, G., Rieder, D., Hackl, H., Krogsdam, A., Posch, W., Wilflingseder, D., Sopper, S., Jsselsteijn, M., Johnsons, D., Xu, Y., Wang, Y., Sanders, M. E., Estrada, M. V., Ericsson-Gonzalez, P., Balko, J., de Miranda, N. F., Trajanoski, Z.. 2017-11-22. quanTIseq: quantifying immune contexture of human tumors. https://doi.org/10.1101/223180
Cite the original work for its findings. Save a collection to share your selection of sources.